Idexx Laboratories IDXX Recurring revenue — Total Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Idexx Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Idexx Laboratories's recurring revenue — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Idexx Laboratories's recurring revenue — total revenue?
- Idexx Laboratories (IDXX) reported recurring revenue — total revenue of $73.54M in Q1 2026.
- How has Idexx Laboratories's recurring revenue — total revenue changed year-over-year?
- Idexx Laboratories's recurring revenue — total revenue increased by 11.8% year-over-year, from $65.79M to $73.54M.
- What is the long-term trend for Idexx Laboratories's recurring revenue — total revenue?
- Over 4 years (2021 to 2025), Idexx Laboratories's recurring revenue — total revenue has grown at a 17.0% compound annual growth rate (CAGR), from $147.5M to $276.34M.
- What does recurring revenue — total revenue mean?
- This metric represents the portion of total revenue generated from recurring sources, such as diagnostic test kits, reference laboratory services, and software subscriptions. It serves as a key indicator of business stability and customer retention within the veterinary diagnostics market. By focusing on recurring streams, the company demonstrates its ability to generate predictable cash flows independent of one-time equipment sales.